SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 309.95 |
| Enterprise Value ($M) | 309.75 |
| Book Value ($M) | -8.22 |
| Book Value / Share | -0.28 |
| Price / Book | -37.71 |
| NCAV ($M) | -246.32 |
| NCAV / Share | -8.34 |
| Price / NCAV | -1.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | 43.80 |
| Return on Equity (ROE) | 241.70 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.00 |
| Current Ratio | 2.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | 238.10 |
| Liabilities | 246.32 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -0.50 |
| Net Income | 4.70 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -0.81 |
| Cash from Investing | -232.30 |
| Cash from Financing | 233.31 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Vivaldi Asset Management, LLC | 5.30 | ||
| 13G | HGC Investment Management Inc. | 8.38 | ||
| 13G | Wealthspring Capital LLC | 9.40 | ||
| 13D | Haymaker Sponsor IV LLC |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 132 | 79,979 | 0.17 | |
| 1,053 | 104,618 | 1.01 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CTLT – Catalent, Inc. | EBS – Emergent BioSolutions Inc. |
| ELAN – Elanco Animal Health Incorporated | JNJ – Johnson & Johnson |
| LLY – Eli Lilly and Company |
Financial data and stock pages provided by
Fintel.io